Peritonsillar cellulitis - Revision history

Rossdonaldson1: /* Background */

2022-01-06T05:04:21Z

Background

← Older revision		Revision as of 05:04, 6 January 2022
Line 1:		Line 1:
	==Background==		==Background==
			[[File:Gray1014.png\|thumb\|Anatomy of the posterior pharynx.]]
	*Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.		*Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.
	*[[Peritonsillar abscess]] - collection of pus located between palatine tonsil and pharyngeal muscle.		*[[Peritonsillar abscess]] - collection of pus located between palatine tonsil and pharyngeal muscle.

Rossdonaldson1 at 04:57, 6 January 2022

2022-01-06T04:57:10Z

← Older revision		Revision as of 04:57, 6 January 2022
Line 7:		Line 7:
	*+/- [[fever]]		*+/- [[fever]]
	*+/- exudates, [[lymphadenopathy]]		*+/- exudates, [[lymphadenopathy]]


	==Differential Diagnosis==		==Differential Diagnosis==

ClaireLewis: /* References */

2019-09-30T22:30:40Z

References

← Older revision		Revision as of 22:30, 30 September 2019
Line 45:		Line 45:

	[[Category:ENT]]		[[Category:ENT]]
			[[category:ID]]

ClaireLewis at 22:30, 30 September 2019

2019-09-30T22:30:25Z

← Older revision		Revision as of 22:30, 30 September 2019
Line 1:		Line 1:
	==Background==		==Background==
	*Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.		*Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.
	*Peritonsillar abscess - collection of pus located between palatine tonsil and pharyngeal muscle.		*[[Peritonsillar abscess]] - collection of pus located between palatine tonsil and pharyngeal muscle.

	==Clinical Features==		==Clinical Features==
	*[[Sore throat]], odynophagia		*[[Sore throat]], odynophagia
	*+/- [[fever]]		*+/- [[fever]]
	*+/- exudates, lymphadenopathy		*+/- exudates, [[lymphadenopathy]]


Line 13:		Line 13:

	==Evaluation==		==Evaluation==
	*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection		*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, [[epiglottitis]], deep space neck infection
	*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration		*Intraoral or submandibular [[ultrasound]] distinguish PTA from cellulitis and guide needle aspiration
	*Submandibular ultrasound may be superior to intraoral ultrasound when limited by trismus or pain.		**Submandibular ultrasound may be superior to intraoral ultrasound when limited by trismus or pain.
	*PTA will have echo-free cavity with irregular border		**PTA will have echo-free cavity with irregular border
	*Peritonsillar cellulitis appears as homogenous area with no fluid collection		**Peritonsillar cellulitis appears as homogenous area with no fluid collection
	* Do not recommend CT to differentiate PTA from cellulitis		* Do not recommend CT to differentiate PTA from cellulitis
	**Recommend CT with IV contrast to identify deep space neck infection		**Recommend CT with IV contrast to identify deep space neck infection

ClaireLewis at 21:32, 27 January 2019

2019-01-27T21:32:46Z

← Older revision		Revision as of 21:32, 27 January 2019
Line 4:		Line 4:

	==Clinical Features==		==Clinical Features==
			*[[Sore throat]], odynophagia
			*+/- [[fever]]
			*+/- exudates, lymphadenopathy


			==Differential Diagnosis==
			{{Sore throat DDX}}

			==Evaluation==
	*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection		*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection
	*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration		*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration
Line 11:		Line 20:
	* Do not recommend CT to differentiate PTA from cellulitis		* Do not recommend CT to differentiate PTA from cellulitis
	**Recommend CT with IV contrast to identify deep space neck infection		**Recommend CT with IV contrast to identify deep space neck infection
	*Clinical features may not always distinguish PTA from cellulitis
	**24-hour trial of antimicrobial therapy may be helpful
	***Response is defined by improvement of sore throat, fever, trismus or alleviation of tonsillar inflammation

	~~==Differential Diagnosis==~~
	~~{{Sore throat DDX}}~~

	~~==Evaluation==~~


	==Management==		==Management==
	*Antibiotic therapy		*Antibiotic therapy
	**Oral		**Oral
	***Amoxicillin-clavulanate (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults		***[[Amoxicillin-clavulanate]] (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults
	***Clindamycin (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults		***[[Clindamycin]] (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults
	**Parenteral		**Parenteral
	***Ampicillin-sulbactam (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults		***[[Ampicillin-sulbactam]] (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults
	***Clindamycin IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults		***[[Clindamycin]] IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults
	***If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV vancomycin or linezolid ~~assed~~ to ampicillin-sulbactam or clindamycin		***If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV [[vancomycin]] or [[linezolid]] to ampicillin-sulbactam or clindamycin

	==Disposition==		==Disposition==
			*Usually discharge

	==See Also==		==See Also==
			*[[PTA]]
			*[[Pharyngitis]]

	==External Links==		==External Links==

Sabedi: /* Background */

2018-10-18T22:30:06Z

Background

← Older revision		Revision as of 22:30, 18 October 2018
Line 1:		Line 1:
	==Background==		==Background==
			*Peritonsillar cellulitis- inflammatory reaction between palatine tonsil and pharyngeal muscle with no discrete collection of pus.
			*Peritonsillar abscess - collection of pus located between palatine tonsil and pharyngeal muscle.

	==Clinical Features==		==Clinical Features==
			*Imaging may be necessary to differentiate peritonsillar abscess (PTA) from peritonsillar cellulitis, epiglottitis, deep space neck infection
			*Intraoral or submandibular ultrasound distinguish PTA from cellulitis and guide needle aspiration
			*Submandibular ultrasound may be superior to intraoral ultrasound when limited by trismus or pain.
			*PTA will have echo-free cavity with irregular border
			*Peritonsillar cellulitis appears as homogenous area with no fluid collection
			* Do not recommend CT to differentiate PTA from cellulitis
			**Recommend CT with IV contrast to identify deep space neck infection
			*Clinical features may not always distinguish PTA from cellulitis
			**24-hour trial of antimicrobial therapy may be helpful
			***Response is defined by improvement of sore throat, fever, trismus or alleviation of tonsillar inflammation

	==Differential Diagnosis==		==Differential Diagnosis==
Line 12:		Line 22:

	==Management==		==Management==
			*Antibiotic therapy
			**Oral
			***Amoxicillin-clavulanate (45mg/kg per dose [max 875mg single dose]) x 12 hours in children; 875 mg x 12 hours in adults
			***Clindamycin (10mg/kg [max 600mg single dose]) x8 hours in children; 300-450mg x 6 hours in adults
			**Parenteral
			***Ampicillin-sulbactam (no MRSA coverage) IV (50mg/kg per dose [max 3g single dose]) x 6 hours children; 3g x6 hours adults
			***Clindamycin IV (13mg/kg per dose [max 900mg single dose]) x8 hours children; 600mg x6-8 hours adults
			***If moderate to severe disease (toxic, temp>39C, drooling, respiratory distress) add IV vancomycin or linezolid assed to ampicillin-sulbactam or clindamycin

	==Disposition==		==Disposition==

Mholtz at 00:49, 9 August 2018

2018-08-09T00:49:33Z

← Older revision		Revision as of 00:49, 9 August 2018
Line 25:		Line 25:
	==References==		==References==
	<references/>		<references/>

			[[Category:ENT]]

Rossdonaldson1: Created page with "==Background== ==Clinical Features== ==Differential Diagnosis== {{Sore throat DDX}} ==Evaluation== ==Management== ==Disposition== ==See Also== ==External Links==..."

2018-06-26T22:29:56Z

Created page with "==Background== ==Clinical Features== ==Differential Diagnosis== {{Sore throat DDX}} ==Evaluation== ==Management== ==Disposition== ==See Also== ==External Links==..."

New page

==Background==

==Clinical Features==

==Differential Diagnosis==
{{Sore throat DDX}}

==Evaluation==

==Management==

==Disposition==

==See Also==

==External Links==

==References==
<references/>